GLP-1 Use Prior to Hemiarthroplasty May Not Increase Medical, Surgical Complications .
Preoperative use of glucagon-like peptide-1 (GLP-1) receptor agonists does not appear to increase medical or surgical complication risk following hemiarthroplasty, according to recent findings. Given the growing use of GLP-1 therapies for diabetes and weight management, concerns have emerged regarding potential perioperative risks, including delayed gastric emptying and metabolic effects. However, available evidence suggests that patients receiving GLP-1 medications did not experience higher rates of postoperative complications compared with those not using these therapies. These findings provide reassurance for clinicians managing patients undergoing hemiarthroplasty, supporting the continued evaluation of GLP-1 therapy within perioperative optimization strategies as use of these agents continues to expand.
Read the full News article from Healio
Read Article
DISCLAIMER
This content found on this page is for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. If you require medical treatment, always seek the advice of your physician or go to your nearest emergency department. The opinions, beliefs, and viewpoints expressed by the individuals on the content found on this page do not reflect the opinions, beliefs, and viewpoints of OrthoEvidence.
